Majestic Ideal Holdings Ltd approved a name change to 'Ping An Biomedical Co., Ltd.' during an Extraordinary General Meeting, reflecting the company's strategic shift towards biomedical and healthcare technologies.

Majestic Ideal Holdings Limited completed its initial public offering of 2,500,000 ordinary shares at $6.00 per share, raising $15 million. The company will use proceeds to enhance supply chain capabilities, source materials, and expand its customer base.